Association between early treatment of multiple sclerosis and patient-reported outcomes: a nationwide observational cohort study.

Earlier commencement of disease-modifying treatment was associated with better patient-reported physical symptoms when measured using a disease-specific metric; however, general quality of life was not affected. This indicates that other factors may inform patients' overall quality of life.